New insights into breast and endometrial cancers

Yasuhiro Miki

doi:10.3390/cancers12092595

New insights into breast and endometrial cancers

Yasuhiro Miki

MED - Medical Sciences

Research output: Contribution to journal › Editorial

5 Citations (Scopus)

Abstract

Cancers of the breast and endometrium are some of the most common cancers affecting women. These cancers show estrogen-dependent proliferation in several cases; therefore, hormone therapeutic strategies are employed. Tamoxifen is an effective hormone therapy that is traditionally used for estrogen receptor-positive breast cancer patients. However, in endometrial cancer, tamoxifen treatment increases the risk of a poor prognosis type of endometrial cancer.

Original language	English
Article number	2595
Pages (from-to)	1-6
Number of pages	6
Journal	Cancers
Volume	12
Issue number	9
DOIs	https://doi.org/10.3390/cancers12092595
Publication status	Published - 2020 Sept

Keywords

Breast cancer
Endometrial cancer
Hormone
Prognostic factor
Therapeutic target molecule

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3390/cancers12092595

Cite this

@article{89a53039e82748c7abfca9040ee70fe2,

title = "New insights into breast and endometrial cancers",

abstract = "Cancers of the breast and endometrium are some of the most common cancers affecting women. These cancers show estrogen-dependent proliferation in several cases; therefore, hormone therapeutic strategies are employed. Tamoxifen is an effective hormone therapy that is traditionally used for estrogen receptor-positive breast cancer patients. However, in endometrial cancer, tamoxifen treatment increases the risk of a poor prognosis type of endometrial cancer.",

keywords = "Breast cancer, Endometrial cancer, Hormone, Prognostic factor, Therapeutic target molecule",

author = "Yasuhiro Miki",

note = "Funding Information: Funding: JSPS KAKENHI Grant Number 19K07453. Publisher Copyright: {\textcopyright} 2020 by the author. Licensee MDPI, Basel, Switzerland.",

year = "2020",

month = sep,

doi = "10.3390/cancers12092595",

language = "English",

volume = "12",

pages = "1--6",

journal = "Cancers",

issn = "2072-6694",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "9",

}

TY - JOUR

T1 - New insights into breast and endometrial cancers

AU - Miki, Yasuhiro

PY - 2020/9

Y1 - 2020/9

N2 - Cancers of the breast and endometrium are some of the most common cancers affecting women. These cancers show estrogen-dependent proliferation in several cases; therefore, hormone therapeutic strategies are employed. Tamoxifen is an effective hormone therapy that is traditionally used for estrogen receptor-positive breast cancer patients. However, in endometrial cancer, tamoxifen treatment increases the risk of a poor prognosis type of endometrial cancer.

AB - Cancers of the breast and endometrium are some of the most common cancers affecting women. These cancers show estrogen-dependent proliferation in several cases; therefore, hormone therapeutic strategies are employed. Tamoxifen is an effective hormone therapy that is traditionally used for estrogen receptor-positive breast cancer patients. However, in endometrial cancer, tamoxifen treatment increases the risk of a poor prognosis type of endometrial cancer.

KW - Breast cancer

KW - Endometrial cancer

KW - Hormone

KW - Prognostic factor

KW - Therapeutic target molecule

UR - http://www.scopus.com/inward/record.url?scp=85092145396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85092145396&partnerID=8YFLogxK

U2 - 10.3390/cancers12092595

DO - 10.3390/cancers12092595

M3 - Editorial

AN - SCOPUS:85092145396

SN - 2072-6694

VL - 12

SP - 1

EP - 6

JO - Cancers

JF - Cancers

IS - 9

M1 - 2595

ER -

New insights into breast and endometrial cancers

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this